Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuroinflammation
Published in: Journal of Neuroinflammation 1/2011

Open Access 01-12-2011 | Research

Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study

Authors: Anna J Henningsson, Ivar Tjernberg, Bo-Eric Malmvall, Pia Forsberg, Jan Ernerudh

Published in: Journal of Neuroinflammation | Issue 1/2011

Login to get access

Abstract

Background

Previous studies indicate that successful resolution of Lyme neuroborreliosis (NB) is associated with a strong T helper (Th) 1-type cytokine response in the cerebrospinal fluid (CSF) followed by a down-regulating Th2 response, whereas the role of the recently discovered Th17 cytokine response is unknown.

Methods

To investigate the relative contribution of different Th associated cytokine/chemokine responses, we used a multiple bead array to measure the levels of CXCL10 (Th1 marker), CCL22 (Th2 marker), IL-17 (Th17 marker) and CXCL8 (general inflammation marker), in serum and in CSF from untreated patients with confirmed NB (n = 133), and non-NB patients (n = 96), and related the findings to clinical data. Samples from patients with possible early NB (n = 15) and possible late NB (n = 19) were also analysed, as well as samples from an additional control group with orthopaedic patients (n = 17), where CSF was obtained at spinal anaesthesia.

Results

The most prominent differences across groups were found in the CSF. IL-17 was elevated in CSF in 49% of the patients with confirmed NB, but was not detectable in the other groups. Patients with confirmed NB and possible early NB had significantly higher CSF levels of CXCL10, CCL22 and CXCL8 compared to both the non-NB group and the control group (p < 0.0001 for all comparisons). Patients in the early NB group, showing a short duration of symptoms, had lower CCL22 levels in CSF than did the confirmed NB group (p < 0.0001). Furthermore, patients within the confirmed NB group showing a duration of symptoms <2 weeks, tended to have lower CCL22 levels in CSF than did those with longer symptom duration (p = 0.023). Cytokine/chemokine levels were not correlated with clinical parameters or to levels of anti-Borrelia-antibodies.

Conclusion

Our results support the notion that early NB is dominated by a Th1-type response, eventually accompanied by a Th2 response. Interestingly, IL-17 was increased exclusively in CSF from patients with confirmed NB, suggesting a hitherto unknown role for Th17 in NB. However, for conclusive evidence, future prospective studies are needed.
Appendix
Available only for authorised users
Literature
1.
Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringér A, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R: An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995, 333: 1319-27. 10.1056/NEJM199511163332004.CrossRefPubMed
2.
Cimmino MA: Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe. European Community Concerted Action on Risk Assessment in Lyme Borreliosis. Infection. 1998, 26: 298-300. 10.1007/BF02962251.CrossRefPubMed
3.
Oschmann P, Dorndorf W, Hornig C, Schäfer C, Wellensiek HJ, Pflughaupt KW: Stages and syndromes of neuroborreliosis. J Neurol. 1998, 245: 262-72. 10.1007/s004150050216.CrossRefPubMed
4.
5.
Weber K: Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis. 2001, 20: 6-13.PubMed
6.
Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H: 5-year follow-up study of patients with neuroborreliosis. Scand J Infect Dis. 2002, 34: 421-5. 10.1080/00365540110080421.CrossRefPubMed
7.
Vrethem M, Hellblom L, Widlund M, Ahl M, Danielsson O, Ernerudh J, Forsberg P: Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand. 2002, 106: 205-8. 10.1034/j.1600-0404.2002.01358.x.CrossRefPubMed
8.
Tjernberg I, Carlsson M, Ernerudh J, Eliasson I, Forsberg P: Mapping of hormones and cortisol responses in patients after Lyme neuroborreliosis. BMC Infect Dis. 2010, 10: 20-10.1186/1471-2334-10-20.PubMedCentralCrossRefPubMed
9.
Forsberg P, Ernerudh J, Ekerfelt C, Roberg M, Vrethem M, Bergström S: The outer surface proteins of Lyme disease Borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-γ): diagnostic and pathogenic implications. Clin Exp Immunol. 1995, 101: 453-60.PubMedCentralCrossRefPubMed
10.
Widhe M, Grusell M, Ekerfelt C, Vrethem M, Forsberg P, Ernerudh J: Cytokines in Lyme Borreliosis: lack of early tumor necrosis factor-alpha and transforming growth factor-beta 1 responses are associated with chronic neuroborreliosis. Immunology. 2002, 107: 46-55. 10.1046/j.1365-2567.2002.01500.x.PubMedCentralCrossRefPubMed
11.
Sjöwall J, Carlsson A, Vaarala O, Bergström S, Ernerudh J, Forsberg P, Ekerfelt C: Innate immune responses in Lyme borreliosis: enhanced tumor necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol. 2005, 141: 89-98. 10.1111/j.1365-2249.2005.02820.x.PubMedCentralCrossRefPubMed
12.
Oksi J, Savolainen J, Pène J, Bòusquet J, Laippala P, Viljanen MK: Decreased interleukin-4 and increased gamma interferon production by peripheral blood mononuclear cells of patients with Lyme borreliosis. Infect Immun. 1996, 64: 3620-3.PubMedCentralPubMed
13.
Ekerfelt C, Ernerudh J, Bunikis J, Vrethem M, Aagesen J, Roberg M, Bergström S, Forsberg P: Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol. 1997, 79: 155-62. 10.1016/S0165-5728(97)00118-5.CrossRefPubMed
14.
Widhe M, Ekerfelt C, Forsberg P, Bergström S, Ernerudh J: IgG subclasses in Lyme borreliosis: a study of specific IgG subclass distribution in an interferon-gamma-predominated disease. Scand J Immunol. 1998, 47: 575-81.PubMed
15.
Ekerfelt C, Jarefors S, Tynngård N, Hedlund M, Sander B, Bergström S, Forsberg P, Ernerudh J: Phenotypes indicating cytolytic properties of Borrelia-specific interferon-gamma secreting cells in chronic Lyme borreliosis. J Neuroimmunol. 2003, 145: 115-26. 10.1016/j.jneuroim.2003.08.037.CrossRefPubMed
16.
Kang I, Barthold SW, Persing DH, Bockenstedt LK: T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun. 1997, 65: 3107-11.PubMedCentralPubMed
17.
Yin Z, Braun J, Neure L, Wu P, Eggens U, Krause A, Kamradt T, Sieper J: T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 1997, 40: 69-79. 10.1002/art.1780400111.CrossRefPubMed
18.
Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P, Ernerudh J: Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis. 2004, 189: 1881-91. 10.1086/382893.CrossRefPubMed
19.
Jarefors S, Janefjord CK, Forsberg P, Jenmalm MC, Ekerfelt C: Decreased up-regulation of the interleukin-12R beta 2-chain and interferon-gamma secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed individuals. Clin Exp Immunol. 2007, 147: 18-27.PubMedCentralPubMed
20.
Harrington LE, Mangan PR, Weaver CT: Expanding the effector CD4 T cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006, 18: 349-56. 10.1016/j.coi.2006.03.017.CrossRefPubMed
21.
Stockinger B, Veldhoen M: Differentiation and function of the Th17 cells. Curr Opin Immunol. 2007, 19: 281-6. 10.1016/j.coi.2007.04.005.CrossRefPubMed
22.
Steinman L: A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007, 13: 139-45. 10.1038/nm1551.CrossRefPubMed
23.
Sallustro F, Lanzavecchia A: Human Th17 cells in infection and autoimmunity. Microbes Infect. 2009, 11: 620-4. 10.1016/j.micinf.2009.04.004.CrossRef
24.
Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF: Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun. 2003, 71: 3437-42. 10.1128/IAI.71.6.3437-3442.2003.PubMedCentralCrossRefPubMed
25.
Kotloski NJ, Nardelli DT, Peterson SH, Torrealba JR, Warner TF, Callister SM, Schell RF: Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol. 2008, 15: 1199-1207. 10.1128/CVI.00129-08.PubMedCentralCrossRefPubMed
26.
Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A, Polenghi A, Benagiano M, Paccani SR, Sambri V, Del Prete G, Baldari CT, Zanotti G, Montecucco C, D'Elios MM, de Bernard M: Borrelia burgdorferi NapA-driven Th17 cell inflammation in Lyme arthritis. Arthrit Rheum. 2008, 58: 3609-17. 10.1002/art.23972.CrossRef
27.
Murdoch C, Finn A: Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000, 95: 3032-43.PubMed
28.
Luster AD, Ravtech JV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987, 166: 1084-97. 10.1084/jem.166.4.1084.CrossRefPubMed
29.
Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD: IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immun. 2002, 168: 3195-3204.CrossRefPubMed
30.
Lepej SZ, Rode OD, Jeren T, Vince A, Remenar A, Barsić B: Increased expression of CXCR3 and CCR5 on memory CD4+ T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11. J Neuroimmunol. 2005, 163 (1-2): 128-34. 10.1016/j.jneuroim.2005.03.005.CrossRefPubMed
31.
Muellegger RR, Means TK, Shin JJ, Lee M, Jones KL, Glickstein LJ, Luster AD, Steere AC: Chemokine signatures in the skin disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma. Infect Immun. 2007, 75 (9): 4621-8. 10.1128/IAI.00263-07.CrossRef
32.
Vulcano M, Albanesi C, Stoppacciaro A, Bagnati R, D'Amico G, Struyf S, Transidico P, Bonecchi R, Del Prete A, Allavena P, Ruco LP, Chiabrando C, Girolomoni G, Mantovani A, Sozzani S: Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol. 2001, 31: 812-22. 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L.CrossRefPubMed
33.
Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW: Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med. 1997, 185: 1595-604. 10.1084/jem.185.9.1595.PubMedCentralCrossRefPubMed
34.
Janeway CA, Travers P, Walport M, Shlomchik MJ: Immunobiology. 2005, Garland Science Publishing
35.
Utgaard JO, Jahnsen FL, Bakka A, Brandtzaeg P, Haraldsen G: Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med. 1998, 188 (9): 1751-1756. 10.1084/jem.188.9.1751.PubMedCentralCrossRefPubMed
36.
Kobayashi Y: The role of chemokines in neutrophil biology. Front Biosci. 2008, 13: 2400-7. 10.2741/2853.CrossRefPubMed
37.
38.
Tibbling G, Link H, Öhman S: Principles of albumin and IgG analyses in neurologic disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977, 37: 385-90.CrossRefPubMed
39.
Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I: EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010, 17 (1): 8-16. 10.1111/j.1468-1331.2009.02862.x.CrossRefPubMed
40.
Peltomaa M, Saxen H, Seppala I, Viljanen M, Pyykkö I: Paediatric facial paralysis caused by Lyme borreliosis: a prospective and retrospective analysis. Scand J Infect Dis. 1998, 30: 269-75. 10.1080/00365549850160927.CrossRefPubMed
41.
Tveitnes D, Oymar K, Natas O: Acute facial nerve palsy in children: how often is it Lyme borreliosis?. Scand J Infect Dis. 2007, 39: 425-31. 10.1080/00365540601105764.CrossRefPubMed
42.
Widhe M, Skogman BH, Jarefors S, Eknefelt M, Eneström G, Nordwall M, Ekerfelt C, Croner S, Bergström S, Forsberg P, Ernerudh J: Up-regulation of Borrelia-specific IL-4- and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis. Int Immunol. 2005, 17 (10): 1283-91. 10.1093/intimm/dxh304.CrossRefPubMed
43.
Henningsson AJ, Malmvall BE, Ernerudh J, Matussek A, Forsberg P: Neuroborreliosis - an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect. 2010, 16 (8): 1245-51.CrossRefPubMed
44.
Nordberg M, Forsberg P, Johansson A, Nyman D, Jansson C, Ernerudh J, Ekerfelt C: Cytotoxic mechanisms may play a role in the local immune response in the central nervous system in neuroborreliosis. J Neuroimmunol. 2011, 232 (1-2): 186-93. 10.1016/j.jneuroim.2010.09.028.CrossRefPubMed
45.
46.
Antonelli A, Rotondi M, Fallahi P, Ferrari SM, Paolicchi A, Romagnani P, Serio M, Ferrannini E: Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine. 2006, 34 (1-2): 32-8. 10.1016/j.cyto.2006.03.012.CrossRefPubMed
Metadata
Title
Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study
Authors
Anna J Henningsson
Ivar Tjernberg
Bo-Eric Malmvall
Pia Forsberg
Jan Ernerudh
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-8-36

Other articles of this Issue 1/2011

Journal of Neuroinflammation 1/2011 Go to the issue

Research

Atorvastatin prevents age-related and amyloid-β-induced microglial activation by blocking interferon-γ release from natural killer cells in the brain

Research

Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis

Research

Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke

Research

Lipopolysaccharide modulates astrocytic S100B secretion: a study in cerebrospinal fluid and astrocyte cultures from rats

Research

Increased expression of cystine/glutamate antiporter in multiple sclerosis

Research

Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors